grant

Non-plasma antithrombotic effects of oral anticoagulants and synergy with hydroxychloroquine

Organization UKRILocation United Kingdom
UKRIUK ResearchGrantActive
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Stroke is the second most common cause of death and morbidity worldwide affecting over 100,000 people each year causing 38,000 deaths and considerable disability, with an estimated annual cost to UK society of £26 billion. One of the major causes of stroke as well as other thromboses (blood clots) is antiphospholipid syndrome (APS); an…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Non-plasma antithrombotic effects of oral anticoagulants and synergy with hydroxychloroquine — UKRI | United Kingdom | Dev Procure